News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kelley Susan L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Kelley Susan L. (Director) has filed a Form 4 on IDEAYA Biosciences, Inc.|
Txns:
| Granted 16,200 options to buy
@ $25.4, valued at
$411.5k
|
|
| 01/19/2023 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 3,269 options to buy
@ $21.27, valued at
$69.5k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 9,570 options to buy
@ $8.27, valued at
$79.1k
|
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $56.46, valued at
$677.5k
|
|
| 01/16/2020 |
4
| Kelley Susan L. (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Unknown transaction of 50,000 shares
@ $20, valued at
$1M
Disposed/sold 20,000 options to buy
@ $2.48, valued at
$49.6k
Disposed/sold 30,000 options to buy
@ $6.96, valued at
$208.8k
Disposed/sold 15,000 options to buy
@ $6.71, valued at
$100.7k
Disposed/sold 15,000 options to buy
@ $5.82, valued at
$87.3k
Disposed/sold 15,000 options to buy
@ $2.78, valued at
$41.7k
Disposed/sold 15,000 options to buy
@ $1.42, valued at
$21.3k
Disposed/sold 15,000 options to buy
@ $1.8, valued at
$27k
Disposed/sold 20,000 options to buy
@ $1.68, valued at
$33.6k
Disposed/sold 20,000 options to buy
@ $1.23, valued at
$24.6k
Disposed/sold 40,000 options to buy
@ $6.21, valued at
$248.4k
|
|
| 07/08/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 24,000 options to buy
@ $22.49, valued at
$539.8k
|
|
| 07/08/2019 |
3
| Kelley Susan L. (Director) has filed a Form 3 on Deciphera Pharmaceuticals, Inc. |
| 06/14/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 22,500 options to buy
@ $0.9, valued at
$20.3k
|
|
| 05/15/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 40,000 options to buy
@ $6.21, valued at
$248.4k
|
|
| 04/04/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 01/07/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 07/11/2018 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 45,000 options to buy
@ $1.35, valued at
$60.8k
|
|
| 05/10/2018 |
4
| Kelley Susan L. (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 20,000 options to buy
@ $2.48, valued at
$49.6k
|
|
| 01/08/2018 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 12,500 options to buy
@ $4.05, valued at
$50.6k
|
|
| 12/08/2017 |
4/A
| Kelley Susan L. (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 07/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
3
| Kelley Susan L. (Director) has filed a Form 3 on Immune Design Corp. |
| 05/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/29/2012 |
4
| Kelley Susan L. (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 15,000 options to buy
@ $5.82, valued at
$87.3k
|
|
|
|
|